E8126

Equilin

• Synonym(e): 1,3,5(10),7-Estratetraen-3-ol-17-on, 3-Hydroxy-1,2,5(10),7-oestratetraen-17-on, 7-Dehydroöstron
• Empirische Formel (Hill-System): C₁₈H₂₀O₂
• CAS-Nummer: 474-86-2
• Molekulargewicht: 268.35
• Beilstein: 2624302
• EG-Nummer: 207-488-6
• MDL-Nummer: MFCD00046223
• UNSPSC-Code: 12352200
• PubChem Substanz-ID: 24894666
• NACRES: NA.77

Eigenschaften

• Biologische Quelle: synthetic (organic)
• Sterilität: non-sterile
• Assay: ≥98% (HPLC)
• Form: powder
• Methode(n): inhibition assay: suitable
• mp (Schmelzpunkt): 238-240 °C (lit.)
• Löslichkeit: chloroform: methanol (1:1): 40 mg/mL, clear, colorless to faintly yellow
• Versandbedingung: ambient
• Lagertemp.: room temp
• SMILES String: C[C@]12CC[C@H]3C(=CCc4cc(O)ccc34)[C@@H]1CCC2=O
• InChI: 1S/C18H20O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3-5,10,14,16,19H,2,6-9H2,1H3/t14-,16+,18+/m1/s1
• InChIKey: WKRLQDKEXYKHJB-HFTRVMKXSA-N

Beschreibung

Biochem./physiol. Wirkung

Equilin is the Mare estrogen and is majorly used in multi-estrogen drugs for hormone replacement therapy. It is synthesized in the microsomes of mare placenta. It mediates estrogen receptor β (ERβ) expression resulting in the activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) which favors monocytes adhesion in atherosclerosis. In vitro equilin inhibits 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) that catalyzes the conversion of estrone to 17β-estradiol.

Sicherheitshinweise

• Piktogramme: GHS08
• Signalwort: Warning
• H-Sätze: H351,H361fd,H362
• P-Sätze: P202 - P260 - P263 - P264 - P270 - P308 + P313
• Gefahreneinstufungen: Carc. 2 - Lact. - Repr. 2
• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable
• Persönliche Schutzausrüstung: Eyeshields, Gloves, type P3 (EN 143) respirator cartridges